SCHEMBL26132525

SCHEMBL26132525

O=CC(=O)C1CCC(N2Cc3c(N4C5CNCC4C5)ccc(F)c3C2=O)CN1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26094915 0.89 — —
SCHEMBL26094622 0.89 — —
SCHEMBL26094753 0.86 PARP1 (0.30) PARP1
SCHEMBL26133268 0.85 MAPK1 (0.33) —
SCHEMBL26094320 0.85 PARP1 (0.31) PARP1
SCHEMBL26132064 0.84 MAP4K1 (0.35) PARP1
SCHEMBL26133341 0.84 PARP1 (0.31) PARP1
SCHEMBL26133298 0.84 MAPK1 (0.35) —
SCHEMBL26133327 0.84 CHRNB2 (0.33) PARP1
SCHEMBL26132966 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023066350-A1 CRBN E3 LIGASE LIGAND COMPOUND, PROTEIN DEGRADING AGENT DEVELOPED ON THE BASIS OF LIGAND COMPOUND, AND THEIR APPLICATIONS 标新生物医药科技(上海)有限公司 2023-04-27 — — WO claimed
Send feedback